Electro-Magnetic-Frequency Therapy (EMF) for Cancer
- Conditions
- CancerCancer - Any cancer
- Registration Number
- ACTRN12624000177550
- Lead Sponsor
- AProf Dr Karin Ried
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
adults diagnosed with cancer
at any stage of their cancer treatment, including
patients undergoing active cancer treatment, and patients in remission as determined by pathology testing following completion of cancer treatment;
patients with electronic implants, e.g. pacemaker, defibrillator, cochlear implant, ring-shaped metals in the body
planning to introduce new treatments during the study period
unable to commit to regular treatment sessions over a 3 month period
unable to give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method